Sprint Bioscience AB Cash Flow Quality Index
Sprint Bioscience AB cash flow quality index. Sprint Bioscience AB (SPRINT) has a Cash Flow Quality Index of 1.02x as of December 2025. Operating cash flow of Skr115.84 Million exceeds net income of Skr113.17 Million, indicating high earnings quality where cash backs reported profits. See financial agility of Sprint Bioscience AB to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sprint Bioscience AB (2016–2025)
Cash flow quality index of Sprint Bioscience AB from 2016 to 2025. Historical Cash Flow Quality Index for Sprint Bioscience AB across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Sprint Bioscience AB to assess how comfortably operating cash covers total debt obligations.
Sprint Bioscience AB Cash Flow Quality Index by Year (2016–2025)
Sprint Bioscience AB cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Sprint Bioscience AB. For the full cash flow conversion analysis, see SPRINT cash generation efficiency.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.91x | Skr83.53 Million | Skr91.74 Million | ▼ -47.6% |
| 2016 | 1.74x | Skr7.93 Million | Skr4.57 Million | — |